EnviroChemie wins order for wastewater deactivation and detoxification from major vaccine producer
The wastewater from vaccine production at a world-leading pharmaceutical company will be safely deactivated and processed before being released into the sewer system.
Plant constructor EnviroChemie has won the order for the planning, construction and commissioning of two wastewater processing plants for the production wastewater from a Benelux pharmaceutical company. The expansion of the production capacity for vaccines also meant an upgrade to the wastewater processing technology.
When producing vaccines, biologically active material is handled. That is why it is necessary to safely deactivate and detoxify the wastewater before it can be fed back indirectly into the system.
Two separate flows of wastewater require treatment. One flow of production wastewater is processed continuously by a thermal deactivation processing plant from the DTS Sterifix series to reach the required discharge levels.
A second flow of wastewater, smaller in volume, is processed thermally in a DTS Sterifix series batch processing plant to deactivate it and then passes through a chemical-physical Envochem cleansing stage. In the chemical-physical cleansing stage toxic barium is removed from the wastewater.
Many years of experience by EnviroChemie engineers with both processes of thermal deactivation and detoxification led the customer to award EnviroChemie the contract.
-
Most popular related searches
Customer comments
No comments were found for EnviroChemie wins order for wastewater deactivation and detoxification from major vaccine producer. Be the first to comment!